TP53 and leukemia: Members of the DNA repair or JAK/STAT pathways are deregulated in both conditions (Fernández et al., 2023; Liang et al., 2024), whereas NFKB is prominently involved in lymphoma development (Grondona et al., 2018), and TP53 or MAPK/RAS is prominently involved in leukemia development (Yu et al., 2020; Pikman and Stieglitz, 2021).